Financhill
Sell
43

CINF Quote, Financials, Valuation and Earnings

Last price:
$147.48
Seasonality move :
3.41%
Day range:
$146.20 - $148.25
52-week range:
$115.43 - $161.75
Dividend yield:
2.28%
P/E ratio:
16.08x
P/S ratio:
2.12x
P/B ratio:
1.68x
Volume:
448.9K
Avg. volume:
560.8K
1-year change:
21.42%
Market cap:
$23B
Revenue:
$11.3B
EPS (TTM):
$9.17

CINF Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for Cincinnati Financial shares anticipate an average target of $155.67, ranging from a low estimate of $134.00 to a high estimate of $167.00. This average target implies a growth of 5.6% compared to the current stock price of $147.41.

Consensus Price Target

$155.67

Highest Price Target

$167.00

Lowest Price Target

$134.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 1 2 2

Hold 4 4 4

Sell 0 0 0
Consensus Hold Hold Hold

CINF Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock